Doublecortin Expression in Prostate Adenocarcinoma and Neuroendocrine Tumors
- 15 November 2020
- journal article
- research article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 108 (4), 936-940
- https://doi.org/10.1016/j.ijrobp.2020.06.024
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Characterization of transcriptomic signature of primary prostate cancer analogous to prostatic small cell neuroendocrine carcinomaInternational Journal of Cancer, 2019
- Progenitors from the central nervous system drive neurogenesis in cancerNature, 2019
- Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective StudyJournal of Clinical Oncology, 2018
- Association of doublecortin-like kinase 1 with tumor aggressiveness and poor biochemical recurrence-free survival in prostate cancerOncoTargets and Therapy, 2018
- Individual Patient-Level Meta-Analysis of the Performance of the Decipher Genomic Classifier in High-Risk Men After Prostatectomy to Predict Development of Metastatic DiseaseJournal of Clinical Oncology, 2017
- Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancerNature Medicine, 2016
- Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk MenEuropean Urology, 2016
- The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate CancerCell Reports, 2015
- Inferring tumour purity and stromal and immune cell admixture from expression dataNature Communications, 2013
- Integrative Genomic Profiling of Human Prostate CancerCancer Cell, 2010